Daily as of 3 Nov 16:00 ET
- Price
- below both $19.90 vs 50 $22.56 / 200 $29.68
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 15 Jun 2026 · projected 10 bars out · tested 2 bars
NAMS | NewAmsterdam Pharma CompanyNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$19.90
+$0.34 (+1.74%)
NewAmsterdam Pharma Company (NAMS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $20.06 vs 50 $30.80 / 200 $21.30
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- below both $20.22 vs 50 $21.32 / 200 $26.58
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 31 Jul 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 31 Jul 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 17 Jul 2026 | 🟨Golden | 4-hour | 27 bars out | 2 bar cross test |
| 22 Jun 2026 | 💀Death | 4-hour | 30 bars out | 5 bar cross test |
| 15 Jun 2026 | 💀Death flat | daily | 10 bars out | 2 bar cross test |
| 22 May 2026 | 🟨Golden moderate | daily | 16 bars out | 2 bar cross test |
About NAMS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$29.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid